Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Plague trackers: Researchers cover thousands of years to understand the elusive origins of the Black Death
Seeking to better understand more about the origins and movement of bubonic plague in ancient and contemporary times, researchers at McMaster University, the University of . . .
Analysis: Working in isolation can pose mental health challenges – here’s what anyone can learn from how gig workers have adapted
In the wake of the pandemic, it is clear that remote work is here to stay. It seems every week there are more news stories . . .
McMaster-led autism study receives funding for expansion across Canada
A major Canadian study of the diverse and changing paths for children with autism, led by McMaster researchers, is being broadened across the country through . . .
Discover how Our Research is making an Impact
